Most pharmaceutical companies know their HCP engagement strategy has challenges. They measure it in rep access rates that keep falling, event attendance that doesn’t convert, and digital campaigns that HCPs scroll past.
The problem isn’t execution. The model itself is under pressure.
HCPs in the UAE and GCC are educated, time-poor and highly aware of when they’re being marketed to. The traditional pharma engagement model (brand-led, rep-delivered, promotion-focused) was built for a different era of HCP attention. That era is over.
Why the old model is losing ground
Three things are working against traditional pharma HCP engagement simultaneously:
- Access is shrinking: Hospital procurement of sales rep access is tighter, appointment availability is lower, and the average meaningful interaction between a rep and a prescriber is shorter than ever before.
- Trust is down: HCPs are more skeptical of promotional messaging than they’ve ever been. It’s clear that clinicians value independent, peer-authored medical education as significantly more credible and useful than brand-sponsored content.
- Attention is scarce: A doctor with 20 minutes between patients isn’t reading branded emails. But they are completing accredited CPD modules that count toward their annual DHA requirement.
The opportunity sits in that last point. CPD is mandatory. Demand is constant. And the HCP who engages with genuinely useful content is far more receptive to a brand who supports their education than one who just serves promotional ads.
The education-led engagement model
The shift to CPD-led HCP engagement isn’t new in theory. What’s changed is the infrastructure available to execute it properly.
MediLearning’s Sponsored Credits programme gives pharma companies a direct, compliant route to fund accredited CPD for HCP groups. The mechanics are simple: purchase credits, set the allocation per user, share a registration link. HCPs engage with independently produced, evidence-based content across their area of practice. Completion data and engagement insights are returned to the sponsor in an anonymised, compliant format.
The content is fully independent. MediLearning’s modules are authored by practising clinicians, audited by independent content boards, and accredited by bodies including the DHA, RCPI and NMBI. The pharma partner’s role is to support education, not to shape the message.
That separation is what makes the trust transfer genuine rather than manufactured.
Building a pharma HCP engagement strategy that works
The companies getting the most out of CPD-led engagement treat it as a long-term brand-building exercise, not a one off campaign. A single credit pack of 5,000 credits reaching 1,200 HCPs at 85% completion delivers a strong ongoing impact. And the brand value compounds over time as those HCPs repeatedly associate your company’s name with supporting their annual CPD requirements.
Used consistently alongside other touchpoints, education-led engagement changes the relationship between brand and clinician from promotional to professional.
Frequently asked questions
What is the difference between CME grants and Sponsored Credits?
A traditional CME grant funds the development of educational content, which is then made available broadly. Sponsored Credits takes a more targeted approach: the pharma company purchases credits and allocates them directly to their specific audience, enabling precise reach and measurable engagement.
How does pharma measure the ROI of HCP education programmes?
Direct metrics include anonymised HCP registration numbers, module completion rates, clinical area engagement, and certificate issuance. Indirect metrics (brand perception, prescriber relationship quality) are harder to quantify but the impact is visible through ongoing engagements and touchpoints.
Can pharma companies choose which clinical areas HCPs access?
The Sponsored Credits model allows HCPs to access content across the platform freely. However, companies can build campaigns that target specific HCP groups whose clinical interests align with the sponsor’s therapeutic focus. The platform covers 30+ clinical areas across four HCP groups.
What is non-promotional HCP engagement in pharma?
Non-promotional HCP engagement covers any activity that provides genuine value to clinicians without a direct promotional intent. Supporting and funding accredited CPD education through an independent platform is one of the clearest examples. It’s compliant, valuable, and trusted by the HCP community.